TARDBP and frontotemporal dementia: Over 90% of ALS cases and 45% of FTD cases exhibit TDP-43 pathology, with nuclear depletion and cytoplasmic aggregation of TDP-43 associated with both loss- and gain-of-function mechanisms, respectively.